Significance of CD44 and CD24 as cancer stem cell markers: an enduring ambiguity
about
Validation of the effects of TGF-β1 on tumor recurrence and prognosis through tumor retrieval and cell mechanical propertiesInduction of stem-like cells with malignant properties by chronic exposure of human lung epithelial cells to single-walled carbon nanotubesImmune targeting of cancer stem cells in gastrointestinal oncologyEmerging role of N-myc downstream-regulated gene 2 (NDRG2) in cancerA review on hepatocyte nuclear factor-1beta and tumorSheep, wolf, or werewolf: cancer stem cells and the epithelial-to-mesenchymal transitionCan nanomedicines kill cancer stem cells?In vitro models of cancer stem cells and clinical applicationsA small molecule (pluripotin) as a tool for studying cancer stem cell biology: proof of conceptAmelioration of cancer stem cells in macrophage colony stimulating factor-expressing U87MG-human glioblastoma upon 5-fluorouracil therapyDynamic Microenvironment Induces Phenotypic Plasticity of Esophageal Cancer Cells Under Flow.Employing an orthotopic model to study the role of epithelial-mesenchymal transition in bladder cancer metastasisNanotechniques Inactivate Cancer Stem Cells.An attempt at a molecular prediction of metastasis in patients with primary cutaneous melanoma.Dynamic changes of CD44 expression from progenitors to subpopulations of astrocytes and neurons in developing cerebellumDihydropyrimidine accumulation is required for the epithelial-mesenchymal transition.Identification of cancer stem-like side population cells in purified primary cultured human laryngeal squamous cell carcinoma epithelia.Cancer stem cells, cancer cell plasticity and radiation therapyIn vitro selection of modified RNA aptamers against CD44 cancer stem cell markerPatterns of cancer cell sphere formation in primary cultures of human oral tongue squamous cell carcinoma and neck nodesPremature aging induced by radiation exhibits pro-atherosclerotic effects mediated by epigenetic activation of CD44 expression.What Tumor Dynamics Modeling Can Teach us About Exploiting the Stem-Cell View for Better Cancer Treatment.In vitro enrichment of ovarian cancer tumor-initiating cellsExtracellular molecules involved in cancer cell invasionInvestigating breast cancer cell behavior using tissue engineering scaffolds.CD44 and CD74: The promising candidates for molecular targeted therapy in oral squamous cell carcinoma.CD147 and Ki-67 overexpression confers poor prognosis in squamous cell carcinoma of oral tongue: a tissue microarray studyImpact of kinesin Eg5 inhibition by 3,4-dihydropyrimidin-2(1H)-one derivatives on various breast cancer cell features.Adhesion glycoprotein CD44 functions as an upstream regulator of a network connecting ERK, AKT and Hippo-YAP pathways in cancer progressionCD95 and CD95L promote and protect cancer stem cellsModelling circulating tumour cells for personalised survival prediction in metastatic breast cancerOptimum 3D Matrix Stiffness for Maintenance of Cancer Stem Cells Is Dependent on Tissue Origin of Cancer Cells.Expression of L1 protein correlates with cluster of differentiation 24 and integrin β1 expression in gastrointestinal stromal tumorsCleaved CD44 intracellular domain supports activation of stemness factors and promotes tumorigenesis of breast cancerSpheroid-Formation (Colonosphere) Assay for in Vitro Assessment and Expansion of Stem Cells in Colon CancerCD24 expression as a marker for predicting clinical outcome and invasive activity in uterine cervical cancerIsolation of All CD44 Transcripts in Human Epidermis and Regulation of Their Expression by Various Agents.Let-7a regulates mammosphere formation capacity through Ras/NF-κB and Ras/MAPK/ERK pathway in breast cancer stem cellsTranscriptional repression of cancer stem cell marker CD133 by tumor suppressor p53.A multi-stage process including transient polyploidization and EMT precedes the emergence of chemoresistent ovarian carcinoma cells with a dedifferentiated and pro-inflammatory secretory phenotype
P2860
Q21246016-73BDB8E6-623F-430C-A51C-72A4E6008B39Q23921936-FD7365C7-8A4A-44B5-AB64-AF357CAD8A5AQ26749015-EB9B6598-3450-40AF-9C14-8FD616AA2E44Q26778509-163E969C-B368-4367-BC19-CF1274D89DFEQ26783312-493F22CC-D1B5-4C77-B715-EB79C3990D6CQ26864979-5D03B5B6-2BB7-40F9-8612-A9321953E6F6Q27022017-C623E802-7E3C-4FB8-A35B-E61632664C1CQ28076101-C5372CDC-5C22-4FC4-9584-AA8147B31089Q28486414-883512F7-6562-43DB-9374-79C76711BA64Q28538154-A8012C89-0331-49BA-8785-1D6FB5099900Q28818141-00F30B6C-BFB5-46BA-B9C2-0E85D289D0D2Q33798322-BB890AC1-973E-41F0-ABBD-4FDB3C173376Q33804264-56A0569B-0854-4D52-BAAE-A871CF610731Q34482829-0F30E256-D3A6-4EDC-AF37-3F086AB828F3Q34544707-759BDE23-4369-4FAE-8121-187725BC9301Q34601999-5607AD00-1500-4F19-A678-F4838E6C534FQ34775928-0EE58A16-4ED2-4D81-9312-4CD993B8A099Q34921599-9E9B8A1B-214B-476B-9077-AC04AFFDC7A5Q35028671-3B306C09-06E2-4261-8C96-2A125C3053F6Q35079015-10688C21-D054-4050-8802-E07C4511A30EQ35093041-B0E01B03-920D-434D-8F0D-65CF6F863833Q35135634-E2B8AFDD-21FC-4F76-B55A-D1F5D4949C16Q35162308-C246A1D7-A351-458E-A781-16E1D9F369A2Q35237503-1A7BDE37-700D-4294-82DC-B19B48902C3FQ35250316-CF602164-6410-4CAD-826B-CDFC5D064D14Q35292720-2C88955C-6A69-48A1-9579-51C4A31704E1Q35417696-B7DCA0AC-6256-4664-AF2F-4B2795024203Q35545078-C533BA05-1810-4F34-A9FF-5D379258D21FQ35545627-BC1F2136-91C3-4EC1-8C32-F02666A1CCA0Q35562681-A292EC96-54AB-4325-806F-C2E3353F9CCDQ35610546-131C95B4-6902-47A2-8A3D-4B6FAFF48798Q35689640-C761E36F-692F-49B1-B132-09F8E550F80CQ35758449-F6A72B46-E2CF-4E1A-8DF9-EBC4FF425EBEQ35832214-E9E66966-218E-4885-82BF-A754C092FCC2Q36024608-394D1925-8809-4737-AB63-4982790F9641Q36094140-068A7EBA-7118-492F-B911-ACF4820E7459Q36098905-8829BFB6-6471-4B9E-9023-CA79157083F3Q36189380-7A8A789E-C83E-4AB4-9410-D6C2D4CEDC39Q36349927-3D9A5EE2-752C-4666-9DE2-09B3D51BA10DQ36545528-ED3C2AA8-6361-43D3-A9B8-286568DD240D
P2860
Significance of CD44 and CD24 as cancer stem cell markers: an enduring ambiguity
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Significance of CD44 and CD24 as cancer stem cell markers: an enduring ambiguity
@ast
Significance of CD44 and CD24 as cancer stem cell markers: an enduring ambiguity
@en
type
label
Significance of CD44 and CD24 as cancer stem cell markers: an enduring ambiguity
@ast
Significance of CD44 and CD24 as cancer stem cell markers: an enduring ambiguity
@en
prefLabel
Significance of CD44 and CD24 as cancer stem cell markers: an enduring ambiguity
@ast
Significance of CD44 and CD24 as cancer stem cell markers: an enduring ambiguity
@en
P2860
P921
P356
P1476
Significance of CD44 and CD24 as cancer stem cell markers: an enduring ambiguity
@en
P2093
Appalaraju Jaggupilli
Eyad Elkord
P2860
P304
P356
10.1155/2012/708036
P5008
P577
2012-05-30T00:00:00Z